resources

Advanced in vitro methods in generic drug product development

Advanced in vitro methods in generic drug product development

Webinar

This content has been restricted to logged in users only.

Create an account to view resources.

Advanced in vitro methods in generic drug product development

Webinar

Zentiva is a generics manufacturer that is developing innovative processes to manufacture APIs, and to formulate the drug product itself.  It is using Pion instruments to better understand the API molecule’s behavior in-vivo and any potential risks to progression are critical in the development of new generic medicines. In this webinar the following topics will be covered:

  • Physicochemical characterization of APIs using Pion’s SirusT3
  • Screening of API solid forms using InForm
  • Precipitation experiments on InForm – screening of precipitation inhibitors and description of factors influencing repeatability of the experiments
  • MacroFlux – indirect identification of API-excipient interactions and risk mitigation for bioequivalence studies
  • Rainbow fiber optic system – use for precipitating systems, comparison with standard offline analysis (UV/HPLC)
Previous post